The EYA1 gene helps guide early development of the ears, kidneys, and parts of the head and neck before birth. If it does not work as expected, it can lead to EYA1 related conditions such as branchiootorenal spectrum, which may involve hearing loss, small skin pits or tags near the ear, neck cysts or openings, and kidney differences. Many variants are harmless, while a few may change how the gene works enough to cause these features.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in LearnHub.
Overview
EYA1Gene function
What if the gene works
The EYA1 gene helps guide early development, especially of the ears, kidneys, and parts of the neck. It supports how cells grow, organize, and turn other genes on at the right time.
Risk
What if the gene does not work
Variants in the EYA1 gene can cause branchiootorenal spectrum condition, often affecting hearing, neck or ear development, and kidney formation. Effects range from mild to more severe, so some people have mainly hearing changes while others also have kidney problems.
Treatment
What does that mean for your treatment
At present, no treatment or drug choice approach tied specifically to the EYA1 gene is established in clinical guidelines. The EYA1 gene is being studied in early cancer research as a possible biomarker and drug target, but this has not changed routine care.
Conditions associated with EYA1
Gene function
What if the gene works
Early in development, the EYA1 gene helps growing tissues follow the right plan. Much of what the EYA1 gene does in the body involves guiding when genes turn on and how cells respond to growth signals. These jobs are especially important while organs are taking shape.
EYA1 helps switch certain genes on at the right time during early development. It usually works with partner proteins so growing tissues can follow a coordinated building plan.
Its protein helps early cells respond to signals about where they are and what they should become. This supports the formation of the ears, kidneys, and some head and neck structures.
EYA1 can remove small chemical tags called phosphate groups from certain proteins. This fine tunes how developmental messages are passed along inside cells.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EYA1 gene can make the EYA1 protein shorter, unstable, or less able to bind its partner proteins, so cells have reduced EYA1 activity. This explains how EYA1 gene variants affect protein function at a molecular level. Some variants leave partial activity, while more severe variants greatly reduce or stop it. In branchiootorenal spectrum condition, that difference can shape which features appear and how early they are noticed.
How variants are linked to conditions
Pathogenic variants in the EYA1 gene are most strongly linked to branchiootorenal spectrum disorder, a condition that can include hearing loss, small openings or lumps on the neck, and kidney differences. Some people with EYA1-related findings have branchiootic syndrome, which affects the ears and neck area without kidney involvement. A confirmed disease-causing variant in the EYA1 gene can help confirm this diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental factors play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For EYA1, risk is mainly shaped by whether a disease-causing gene change is present, often because it runs in a family. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower the chance of developing the condition. What can change outcomes is early hearing and kidney checks, which can help find problems sooner.
Inheritance of EYA1 variants
EYA1-related conditions are usually inherited in an autosomal dominant pattern. That means a person with an EYA1 gene variant has a 50% chance of passing it on to each child, regardless of sex. This is the main answer to how EYA1 variants are inherited in families affected by branchiootorenal spectrum conditions. Some people have a new, de novo variant in the EYA1 gene, which means it started in them and was not inherited from either parent.
What does my EYA1 result mean for my family?
For EYA1, family impact is most often tied to a dominant pattern, which means close relatives such as parents, brothers, sisters, and children may also carry the same gene change. Each child of someone with an EYA1-related condition can have a 1 in 2, or 50%, chance of inheriting it. Some cases start as a new gene change in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the EYA1 gene, doctors use genetic testing for EYA1 variants on a blood or saliva sample. A lab reads the gene’s DNA code and looks for variants. Results can show a disease-causing variant, a harmless variant, or an uncertain finding that needs clinical interpretation.
When should I consider getting a genetic test?
Consider EYA1 genetic testing if you or your child has a pattern of early hearing loss, small pits or tags near the ears, cysts or openings on the side of the neck, or kidney differences, especially when these run in the family. Testing can help confirm whether these features are part of an inherited condition linked to EYA1.
A genetic result is only one part of your health story
A genetic test result can provide useful insight, but how much it can tell you depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic findings can also help put a person’s experience into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, how strongly it works, or how sensitive someone is to side effects. This helps explain why the same treatment may work well for one person but less well for another, even when they have the same condition.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medications. It studies links between genes and drugs to help explain why the same treatment can work differently in different people. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the EYA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about side effects, new symptoms, or how medicines fit with your overall health are best discussed with your doctor.
History
The EYA1 gene entered medical genetics through work on inherited patterns of hearing changes, neck cysts or small openings, and kidney differences seen in some families. In the 1990s, researchers linked these family patterns to chromosome 8, which narrowed the search to the responsible gene. Building on this early work, scientists identified the EYA1 gene in 1997 and connected variants in it with branchio-oto-renal syndrome, now often called BOR syndrome. Its name also reflected earlier developmental biology research, because EYA1 is related to the fruit fly gene called eyes absent. That link helped connect rare inherited conditions with broader research on how organs form before birth.